Ligand Pharmaceuticals
LGND
#3389
Rank
โ‚น412.41 B
Marketcap
โ‚น20,682
Share price
-0.82%
Change (1 day)
132.13%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : โ‚น50.34 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are โ‚น50.34 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น48.78 B410.76%
2024-12-31โ‚น9.55 B32.94%
2023-12-31โ‚น7.18 B-47.44%
2022-12-31โ‚น13.66 B-61.45%
2021-12-31โ‚น35.46 B-25.72%
2020-12-31โ‚น47.73 B-8%
2019-12-31โ‚น51.89 B6.04%
2018-12-31โ‚น48.93 B203.69%
2017-12-31โ‚น16.11 B2.77%
2016-12-31โ‚น15.67 B4.33%
2015-12-31โ‚น15.02 B1.5%
2014-12-31โ‚น14.80 B334.96%
2013-12-31โ‚น3.40 B-20.06%
2012-12-31โ‚น4.25 B-28.38%
2011-12-31โ‚น5.94 B65.02%
2010-12-31โ‚น3.60 B-43.76%
2009-12-31โ‚น6.40 B-26.69%
2008-12-31โ‚น8.73 B54.46%
2007-12-31โ‚น5.65 B-57.23%
2006-12-31โ‚น13.22 B-30.83%
2005-12-31โ‚น19.12 B8.3%
2004-12-31โ‚น17.66 B10.32%
2003-12-31โ‚น16.00 B65.74%
2002-12-31โ‚น9.65 B14.16%
2001-12-31โ‚น8.46 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚น10.900 T 21,552.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น11.245 T 22,237.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น7.961 T 15,714.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น7.590 T 14,976.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚น1.292 T 2,467.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น7.800 T 15,395.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น6.626 T 13,063.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น5.634 T 11,092.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
โ‚น7.49 B-85.12%๐Ÿ‡บ๐Ÿ‡ธ USA